Advances in the Treatment of Sickle Cell Disease: Moving Toward a Cure — On Demand


Advances in the Treatment of Sickle Cell Disease: Moving Toward a Cure — On Demand Banner



Date & Location
Friday, June 20, 2025, 8:00 AM - Friday, January 30, 2026, 4:00 PM

Specialties
Specialties - All Specialties

Overview

The management of patients with Sickle Cell Disease (SCD) is a highly specialized field of hematology, growing in complexity due to advances in gene therapy and the rising frequency of hematopoietic stem cell transplants. This requires that healthcare providers, particularly those new to caring for patients with Sickle Cell Disease, be well-versed in advanced treatments and the management of this vulnerable and often underserved population.

Originally recorded live May 7—8, 2025, this complimentary on-demand symposium offers a foundational overview and explores the latest advances in Sickle Cell Disease, including pathophysiology, advances in medical management, stem cell transplant and gene therapy, management of multi-system complications, psychosocial implications, and accessibility to the wide spectrum of care from a global health perspective.

For a complete list of topics and speakers, view the brochure from the live program.

This program is intended for nurse practitioners, physician assistants, nurses, physicians, and students interested in the complex care of patients with Sickle Cell Disease.


Objectives
At the conclusion of this symposium, learners will be able to:

  1. Discuss the pathophysiology and genetic implications of SCD
  2. Address the common complications and clinical management of patients living with SCD
  3. Identify unique opportunities for individualized pain management utilizing evidenced based guidelines based on pain science for patients with SCD
  4. Recall current clinical management of acute vaso occlusive crisis in patients with SCD
  5. Identify mental health challenges and issues of health care equity in this patient population.
  6. Recognize the role of gene therapy and hematopoietic stem cell transplant, unique complications and management of patients with SCD

Registration

This on-demand symposium is available at no cost to all learners.

To enroll, please click the "Register" tab at the top of the page. Once registered, all materials—including instructions for claiming credit—will be available under the "Course Content" tab. On-demand access and the ability to claim credit will remain available through January 30, 2026.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Recorded/Review Date: May 7-8, 2025 | Original Release Date: June 20, 2025 | Termination Date: January 30, 2026